| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Medtronic Plc (MDT) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. MDT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 246.4K | $19.55M | - | |
| VP | 54.7K | $4.34M | - | |
| VP | 50.8K | $4.03M | - | |
| VP | 46.5K | $3.69M | - | |
| CFO | 40.0K | $3.17M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2021 | Anderson Richard H62 | Director | Buy | 5,010 | $103.26 | $517,332.60 | +4.8% | +5.6% | -22.8% | |
| Dec 6, 2021 | Parkhill Karen L63 | EVP &Chief Financial Officer | Sell | 682 | $110.00 | $75,020.00 | -1.9% | -2.6% | -28.1% | |
| Sep 30, 2021 | Lerman Bradley E70 | SVP General Counsel &Corp Sec | Sale+OE | 49,147 | $126.58 | $6,221,027.26 | -50.2% | -16.5% | -33.8% | |
| Aug 31, 2021 | Lerman Bradley E70 | SVP General Counsel &Corp Sec | Sale+OE | 50,775 | $134.17 | $6,812,481.75 | -51.0% | -17.0% | -32.5% | |
| Aug 25, 2021 | Salmon Sean52 | EVP &Pres Diabetes/ Cardiovasc | Sale+OE | 28,419 | $134.08 | $3,810,492.42 | -29.9% | -15.3% | -29.8% | |
| Aug 25, 2021 | Martha Geoffrey52 | CEO | Sale+OE | 11,581 | $132.67 | $1,536,451.27 | -5.7% | -15.3% | -29.8% | |
| Aug 2, 2021 | Lerman Bradley E70 | SVP General Counsel &Corp Sec | Sell | 4,000 | $131.52 | $526,080.00 | -7.7% | -8.0% | -27.2% | |
| Jun 28, 2021 | Martha Geoffrey52 | CEO | Sale+OE | 11,500 | $125.29 | $1,440,835.00 | -12.3% | +4.6% | -26.1% | |
| Jun 21, 2021 | Wall Brett A.60 | EVP &Pres Neuroscience | Sale+OE | 115 | $123.50 | $14,202.50 | -0.5% | +3.1% | -27.7% | |
| Jun 15, 2021 | Parkhill Karen L63 | EVP &Chief Financial Officer | Sell | 605 | $124.47 | $75,304.35 | -0.7% | +4.4% | -27.0% |